The General Approach to Cystic Fibrosis Pulmonary Infection in The Netherlands
Chapter
Summary
In the Netherlands, a national registry provides patient data on the demography of cystic fibrosis (CF). The survival rate of patients with CF has increased considerably over the last decade. The improved survival rate is in part attributable to management and care of these patients by multidisciplinary treatment in CF centres. Early diagnosis of CF, preferably made at the neonatal stage, will lead to improved patient treatment in order to delay deterioration in lung function. Treatment involves a comprehensive approach based on intensive antiobiotic therapy and physiotherapy in addition to nutritional and psychosocial support. Improvement of selective culture media has resulted in enhanced recovery of bacterial pathogens in CF, resulting in better basis for a rational choice of the antibiotic regimen. The complex pathogenic bacterial flora usually requires a combined therapeutic antibiotic treatment, especially for Pseudomonoas aeruginosa infections. The cornerstone of pulmonary care in CF is prevention of pulmonary deterioration through physiotherapy in combination with prophylactic antimicrobial therapy, an optimal nutritional state and possibly vaccination.
Keywords
Cystic Fibrosis Cystic Fibrosis Patient Fusidic Acid Penicillin Allergy Chest Physiotherapy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.Ten Kate LP. Cystic fibrosis in the Netherlands. Int J Epidem 1977; 6: 23–34.CrossRefGoogle Scholar
- 2.Collée JM, Cobben JM, ten Kate LP. Survival of cystic fibrosis patients in the Netherlands. 11`h international cystic fibrosis congress, Dublin, Ireland, August 24–27 1992; TP 104 (abstr.)Google Scholar
- 3.Dankert-Roelse JE, to Meerman GJ. Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre. Thorax 1995; 50: 712–8.PubMedCrossRefGoogle Scholar
- 4.Hoiby N. Microbiology of lung infections in cystic fibrosis patients. Acta Paediatr Scand 1982; 301: suppl: 33–54.CrossRefGoogle Scholar
- 5.Abman SH, Ogle JW, Harbeck RJ, Butler-Simon N, Hammond KB, Accurso FJ. Early bacteriologic, immunologic anc clinical courses of young infants with cystic fibrosis identified by neonatal screening. J. Pediatr 1991; 119: 211–17.PubMedCrossRefGoogle Scholar
- 6.Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991; 4: 35–51.PubMedGoogle Scholar
- 7.Möller LVM, Ruys GJ, Heijerman HGM, Dankert J, van Alphen L. Haemophilus influenzae is frequently detected with monoclonal antibody 8BD9 in sputum samples from patients with cystic fibrosis. J Clin Microbiol 1992; 30: 2495–97.PubMedGoogle Scholar
- 8.Rayner RJ, Hiller EJ, Ispahani P, Baker M. Haemophilus infection in cystic fibrosis. Arch Dis Child 1990; 65: 255–58.PubMedCrossRefGoogle Scholar
- 9.van Doern G, Brogden-Torres B. Optimum use of selective plated medium in primary processing of respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol 1992; 30: 2740–42.PubMedGoogle Scholar
- 10.Mouton JW. Pharmacokinetic and pharmacodynamic studies of beta-lactam antibiotics in volunteers and patients with cystic fibrosis [dissertation]. Rotterdam, The Netherlands: Univ. of Rotterdam, 1993.Google Scholar
- 11.Pseudomonas cepacia - more than a harmless commensal [editoral]. Lancet 1992; 339: 1385–86.CrossRefGoogle Scholar
- 12.Möller LVM, van Alphen L, Grasselier H, Dankert J. N-acetyl-D-glucosamine medium improves recovery of Haemophilus influen:ae from sputum of patient with cystic fibrosis. J Clin Microbiol 1993; 31: 1952 54.Google Scholar
- 13.Fiel SB. Clinical management of pulmonary disease in cystic fibrosis. Lancet 1993; 341: 1070 74.Google Scholar
- 14.Glass S, Hayward C. Serum C-reactive protein in assessment of pulmonary exacerbations and antimicrobial therapy in cystic fibrosis. J Pediatr 1988; 113(1): 76 79.PubMedCrossRefGoogle Scholar
- 15.Greene KE, Takasugi JE, Godwin JD, Richardson ML, Burke W, Aitken ML. Radiographic changes in acute exacerbations of cystic fibrosis in adults: a pilot study. Am J Roentgenol 1994; 163 (3): 557–62.Google Scholar
- 16.Mouton JW, Kerrebijn KF. Antibacterial therapy in cystic fibrosis. Med Clin North Am 1990; 74: 837 55.Google Scholar
- 17.Hoiby N. Haemophilus inJluen_ae, Staphylococcus aureus, Pseudomonas cepacia,and Pseudomonas aeruginosa in patients with cystic fibrosis. Chest 1988; 94: 97S 1025.Google Scholar
- 18.Michel BC. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987. Chest 1988; 94: 1295- I39S.Google Scholar
- 19.Aidons PM. A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis. J Antimicrob Chemother 1991: 27: A: 101–108.Google Scholar
- 20.Bosso JA. Advances in the pharmacotherpy of cystic fibrosis. J Clin Pharm Ther 1992; 17: 263–70.PubMedCrossRefGoogle Scholar
- 21.Bakker W, Vinks AATMM, Mouton JW, de Jonge P, Verzijl JG, Heijerman HGM. Continue intraveneuze thuisbehandeling van luchtweginfecties met ceftazidim via een draagbare pomp bij patienten met cystische fibrose; een multicentrisch onderzoek. Ned Tijdschr Geneeskd 1993; 137: 2486–91.PubMedGoogle Scholar
- 22.Oberwaldner B, Theissl B, Rucker A, Zach MS. Chest physiotherapy in hospitalized patients with cystic fibrosis: A study of lung function effects and sputum production. Eur Respir J 1991; 4: 152 58.Google Scholar
- 23.MacLusky IB, Gold R, Corey M, Levison H. Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol 1989: 7: 42–48.PubMedCrossRefGoogle Scholar
- 24.Valerius NG, Koch C, Hoihy N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early antibiotic treatment. Lancet 1991; 338: 725–26.PubMedCrossRefGoogle Scholar
- 25.Corey M. McLaughlin FJ, Williams M, Levison HA. Comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41: 583–91.PubMedCrossRefGoogle Scholar
- 26.Heijerman HGM. Studies in the clinical management of cystic fibrosis [dissertation]. Leiden, The Netherlands: Univ. of Leiden, 1991.Google Scholar
Copyright information
© Birkhäuser Verlag, Basel, Switzerland 1996